Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
Clinical trial NCT07321067 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07321067
- Sponsor
- Ahmed Karam Helmy
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-01
- Primary completion
- 2026-11-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.